This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm fixed price of $423,530.64 and a completion date of February 23, 2021. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that produces a range of drug products, including vaccines, for U.S. government agencies like the Department of Defense...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract, valued at $158,804.73, has a firm fixed price and an ultimate completion date of September 24, 2024. The contract was awarded on September 18, 2024, and is not set aside for any specific business category. Teva Pharmaceuticals USA, Inc. is a major supplier...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $476,414.19 award is for the supply of Adenovirus Type 4, a vaccine, with a completion date of January 30, 2024. This contract is not set aside for any specific business designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries Ltd., a leading global...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This contract, which has a completion date of May 21, 2024, supports military immunization programs. Teva Pharmaceuticals USA, Inc. has a long history of supplying critical pharmaceuticals, including other vaccines and medications, to various federal...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract is a firm-fixed-price delivery order with a potential value of $271,494.00 and a completion date of December 15, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products, including vaccines, antiviral...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a period of performance through November 19, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract is a firm-fixed price Delivery Order with a potential value of $135,747.00 and a completion date of July 28, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, for U.S. government...